...
首页> 外文期刊>Journal of materials science >Effect of the calcium to phosphorus ratio on the setting properties of calcium phosphate bone cements
【24h】

Effect of the calcium to phosphorus ratio on the setting properties of calcium phosphate bone cements

机译:钙磷比对磷酸钙骨水泥固化性能的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

α -Tricalcium phosphate (α -TCP) has become the main reactant of most experimental and commercial ceramic bone cements. It has calcium-to-phosphorus (Ca/P) ratio of 1.50. The present study expands and reports on the microstructures and mechanical properties of calcium phosphate (CP) cements containing sintered monolithic reaetants obtained in the interval 1.29 < Ca/ P < 1.77. The study focuses on their cement setting and hardening properties as well as on their microstructure and crystal phase evolution. The results showed that: (a) CP-cements made with reaetants with Ca/P ratio other than 1.50 have longer setting and lower hardening properties; (b) CP-cements reactivity was clearly affected by the Ca/P ratio of the starting reactant; (c) reaetants with Ca/P < 1.50 were composed of several phases, calcium pyrophosphate and a- and J5-TCP. Similarly, reaetants with Ca/P > 1.50 were composed of a-TCP, tetracalcium phosphate and hydroxyapatite; (d) only the reactant with Ca/P = 1.50 was monophasic and was made of a-TCP, which transformed during the setting into calcium deficient hydroxyapatite; (e) CP-cements developed different crystal microstructures with specific features depending on the Ca/P ratio of the starting reactant.
机译:α-磷酸三钙(α-TCP)已成为大多数实验和商业陶瓷骨水泥的主要反应物。它的钙磷比(Ca / P)为1.50。本研究扩展并报道了在1.29 1.50的析出物由α-TCP,磷酸四钙和羟基磷灰石组成。 (d)仅Ca / P = 1.50的反应物是单相的,由a-TCP制成,在凝固过程中转变为钙缺乏的羟基磷灰石; (e)CP水泥根据起始反应物的Ca / P比形成具有特定特征的不同晶体微结构。

著录项

  • 来源
    《Journal of materials science》 |2012年第9期|p.2081-2090|共10页
  • 作者单位

    Interdepartment Research Group for the Applied Scientific Collaboration (IRGASC), Division of Biomaterials & Bioengineering, Technical University of Catalonia (UPC), Avda. Diagonal 647, 08028 Barcelona, Spain,Faculty of Medical Bioengineering, 'Gr. T. Popa' University of Medicine and Pharmacy, Str. Kogalniceanu 9-13, 700454 Iasi, Romania;

    Interdepartment Research Group for the Applied Scientific Collaboration (IRGASC), Division of Biomaterials & Bioengineering, Technical University of Catalonia (UPC), Avda. Diagonal 647, 08028 Barcelona, Spain;

    Interdepartment Research Group for the Applied Scientific Collaboration (IRGASC), Division of Biomaterials & Bioengineering, Technical University of Catalonia (UPC), Avda. Diagonal 647, 08028 Barcelona, Spain;

    Interdepartment Research Group for the Applied Scientific Collaboration (IRGASC), Division of Biomaterials & Bioengineering, Technical University of Catalonia (UPC), Avda. Diagonal 647, 08028 Barcelona, Spain;

    Interdepartment Research Group for the Applied Scientific Collaboration (IRGASC), Division of Biomaterials & Bioengineering, Technical University of Catalonia (UPC), Avda. Diagonal 647, 08028 Barcelona, Spain,Department of Materials Science and Metallurgical Engineering, Technical University of Catalonia (UPC), Avda. Diagonal 647, 08028 Barcelona, Spain;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号